RE:RE:Bloom Burton ... FYIDoccole wrote: Just watched it. They anticipate a run up going into phase 2.
do we think they will announce Nasdq uplist in the fall?
how high at best and worst can we expect our MC going into phase 2?
Oh my Doccole - that's a lot of questions ...
I will try to answer the NASDAQ question ... as he did give a little shout-out to the NASDAQ crew on his team. That's a good thing.
The NASDAQ move is likely going to depend on a few things ...
first - the share price movement
2nd - the appetite from the US side
3rd - expected ATE advances and drug development
Therefore, I wouldn't bet on a 2022 co-list on the NASDAQ but I wouldn't rule it out completely. I would be more inclined to bet on it happening in 2023 - but - you just never know if/when sentiment changes.
Regardless - the focus is on the science and getting to P2 and figuring out chronic. There is no rush to get to the NASDAQ because we simply don't need to.
All in my opinion.